CINECA IRIS Institutional Research Information System

FOGLI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.452
EU - Europa 4.393
AS - Asia 4.279
SA - Sud America 617
AF - Africa 217
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 3
Totale 18.996
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.148
SG - Singapore 1.461
IT - Italia 1.403
CN - Cina 1.276
DE - Germania 717
HK - Hong Kong 655
SE - Svezia 643
BR - Brasile 523
GB - Regno Unito 346
BG - Bulgaria 286
CA - Canada 220
VN - Vietnam 194
TR - Turchia 190
RU - Federazione Russa 163
IN - India 148
FI - Finlandia 146
AT - Austria 132
FR - Francia 118
CI - Costa d'Avorio 81
PL - Polonia 81
UA - Ucraina 75
JP - Giappone 60
KR - Corea 51
MX - Messico 49
GR - Grecia 47
NL - Olanda 42
BD - Bangladesh 40
BE - Belgio 38
CH - Svizzera 38
ES - Italia 37
SN - Senegal 37
AR - Argentina 33
AU - Australia 32
IL - Israele 24
ZA - Sudafrica 24
IR - Iran 22
PK - Pakistan 22
ID - Indonesia 21
MA - Marocco 20
NG - Nigeria 18
SA - Arabia Saudita 18
IQ - Iraq 17
RO - Romania 17
CO - Colombia 14
VE - Venezuela 13
EC - Ecuador 12
PT - Portogallo 11
RS - Serbia 11
EG - Egitto 10
AE - Emirati Arabi Uniti 9
TW - Taiwan 9
KE - Kenya 8
NP - Nepal 7
UY - Uruguay 7
UZ - Uzbekistan 7
CZ - Repubblica Ceca 6
HU - Ungheria 6
JM - Giamaica 6
MY - Malesia 6
PH - Filippine 6
DO - Repubblica Dominicana 5
JO - Giordania 5
LT - Lituania 5
TT - Trinidad e Tobago 5
AL - Albania 4
AZ - Azerbaigian 4
CL - Cile 4
ET - Etiopia 4
LB - Libano 4
PA - Panama 4
PE - Perù 4
PY - Paraguay 4
TN - Tunisia 4
BJ - Benin 3
BO - Bolivia 3
BY - Bielorussia 3
CY - Cipro 3
DM - Dominica 3
IE - Irlanda 3
KG - Kirghizistan 3
KZ - Kazakistan 3
NO - Norvegia 3
SV - El Salvador 3
TH - Thailandia 3
A1 - Anonimo 2
AM - Armenia 2
AO - Angola 2
BB - Barbados 2
CR - Costa Rica 2
DK - Danimarca 2
DZ - Algeria 2
GD - Grenada 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SI - Slovenia 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
Totale 18.978
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.048
Ashburn 965
Singapore 728
Fairfield 702
Hong Kong 644
Santa Clara 630
Ann Arbor 604
Chandler 604
Houston 562
Dallas 514
Serra 307
Shanghai 298
Sofia 284
Seattle 278
Wilmington 265
Beijing 258
Cambridge 213
New York 211
Milan 207
Boardman 159
Ottawa 157
Los Angeles 153
Princeton 144
Pisa 120
Lawrence 119
Vienna 118
London 106
Izmir 105
Medford 105
Jacksonville 94
Florence 88
Nanjing 86
Munich 84
Abidjan 81
Hefei 81
Frankfurt am Main 72
Rome 68
Dearborn 67
Warsaw 67
Des Moines 61
Dong Ket 54
Redwood City 54
Redondo Beach 53
São Paulo 51
Buffalo 47
Istanbul 46
Ogden 45
Seoul 44
Tokyo 44
Lancaster 40
Dakar 37
Turku 36
Marseille 35
Nanchang 34
Bern 33
San Diego 33
Ho Chi Minh City 30
The Dalles 29
Council Bluffs 28
Brussels 27
Columbus 27
Jüchen 25
Falls Church 24
Hanoi 24
Phoenix 24
Bremen 22
Kunming 22
Pune 22
Toronto 22
Fuzhou 21
Tianjin 21
Changsha 20
Nürnberg 20
San Jose 20
Chicago 19
Guangzhou 19
San Francisco 19
Belo Horizonte 18
Lagos 18
Montreal 17
Rio de Janeiro 17
Brooklyn 15
Cascina 15
Helsinki 15
Mumbai 15
Norwalk 15
Shenyang 15
Brasília 14
Lucca 14
Naples 14
Pistoia 14
Stockholm 14
Wuhan 14
Chennai 13
Hebei 13
Johannesburg 13
Livorno 13
Quanzhou 13
Düsseldorf 12
Tel Aviv 12
Totale 12.961
Salva come PNG Salva come JPEG
Nome #
Cytotoxic Activity of Oleocanthal Isolated from Virgin Olive Oil on Human Melanoma Cells 339
The molecular bases of cannabinoid action in cancer 327
AM251 induces apoptosis and G2/M cell cycle arrest in A375 human melanoma cells 292
Synthesis of Novel 3,5-Disubstituted-2-oxindole Derivatives As Antitumor Agents against Human Nonsmall Cell Lung Cancer 278
Anticancer activity of euplotin C, isolated from the marine ciliate euplotes crassus, against human melanoma cells 254
Circulating MicroRNAs in Cutaneous Melanoma Diagnosis and Prognosis 247
Sucrosomial iron and traditional iron dosage forms are compared for absorption by Caco2 cells. 232
Oleocanthal and oleacein contribute to the in vitro therapeutic potential of extra virgin oil-derived extracts in non-melanoma skin cancer 228
Cholinesterase-like organocatalysis by imidazole and imidazole-bearing molecules 227
Cannabinoid derivatives induce cell death in pancreatic MIA PaCa-2 cells via a receptor-independent mechanism 223
Variable correlation between 6-mercaptopurine metabolites in erythrocytes and hematologic toxicity: implications for drug monitoring in children with acute lymphoblastic leukemia 221
A flexible SNP genotyping system to study allelic determinants of brain function. 219
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity 217
Protective effect of high-dose montelukast on salbutamol-induced homologous desensitisation in airway smooth muscle. 209
Survivin-directed molecular beacon as potential theranostic agent in melanoma cells 209
Anti-proliferative activity of oleocanthal in human malignant cutaneous melanoma cells 203
Selection of a human butyrylcholinesterase-like antibody single-chain variable fragment resistant to AChE inhibitors from a phage library expressed in E. coli. 199
Analysis of the Antitumor Activity of Clotrimazole on A375 Human Melanoma Cells 198
Rosiglitazone reverses salbutamol-induced ß(2) -adrenoceptor tolerance in airway smooth muscle. 195
Diclofenac-Derived Hybrids for Treatment of Actinic Keratosis and Squamous Cell Carcinoma 191
Detection and silencing of survivin mRNA by bi-color imaging based on PMMA nanoparticles/molecular beacon in human cancer cells 190
Comparison of digital PCR systems for the analysis of liquid biopsy samples of patients affected by lung and colorectal cancer 189
Anticancer activity of anandamide in human cutaneous melanoma cells 189
Chronic administration of suramin induces neurotoxicity in rats 188
Survivin mRNA detection and silencing by a Molecular Beacon Oligodeoxynucleotide in living cutaneous melanoma cells 183
Identification of plasma microRNAs as new potential biomarkers with high diagnostic power in human cutaneous melanoma. 181
Tumor-promoting effects of cannabinoid receptor type 1 in human melanoma cells. 180
Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients 178
Lung tissue penetration and plasma pharmacokinetics of azithromycin after multiple oral doses of 500 and 1000 mg in adults 177
Survivin directed molecular beacon as potential “theranostic agent” in melanoma cells 177
The emerging role of liquid biopsy in diagnosis, prognosis and treatment monitoring of pancreatic cancer 176
Role of miR-34a as biomarker and therapeutic agent in cutaneous melanoma 175
An improved HPLC method for therapeutic drug monitoring of daunorubicin, idarubicin, doxorubicin, epirubicin, and their 13-dihydro metabolites in human plasma. 174
Synergistic interaction between PPAR ligands and salbutamol on human bronchial smooth muscle cell proliferation. 173
Synthesis and in-vitro antitumour activity of new naphthyridine derivatives on human pancreatic cancer cells 171
Cytotoxic effects of Echinacea root hexanic extracts on human cancer cell lines 168
Identification of five circulating microRNAs with high diagnostic values in cutaneous melanoma 167
Antiproliferative effects of Echinacea root hexanic extracts on Mia Paca-2 cells 165
Montelukast prevents microparticle-induced inflammatory and functional alterations in human bronchial smooth muscle cells. 165
Cannabinoid derivatives induce cell death in MIA Paca-2 cell line via a receptor-indipendent mechanism 164
Genotype-based therapeutic approach for colorectal cancer: state of the art and future perspectives 163
Theranostic properties of a survivin-directed molecular beacon in human melanoma cells 162
Matrix metalloproteinase inhibitors prevent the release and proteolytic activity of monocyte/macrophage-derived microparticles 162
Potential relationship between the expression of Cx26/Cx43 and the BRAF mutation status in human melanoma cells 161
Pharmacogenetic determinants of anti-cancer drug activity and toxicity 159
Application of a pharmacokinetic/pharmacogenetic approach to assess the nicotine metabolic profile of smokers in the real-life setting 159
Clinical pharmacology of intravitreal anti-VEGF drugs 158
Understanding the Mechanisms of Resistance in EGFR-Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy 158
Diagnosis and treatment monitoring in breast cancer: how liquid biopsy can support patient management 158
A flexible SNP genotyping system to study allelic determinants of brain function 154
Ceramide analogues in apoptosis: a new strategy for anticancer drug development 154
Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer 154
Drug distribution and pharmacokinetic/pharmacodynamic relationship of paclitaxel and gemcitabine in patients with non-small-cell lung cancer 154
Implications of KRAS mutations in acquired resistance to treatment in NSCLC 153
Circulating microRNAs as biomarkers for early diagnosis of cutaneous melanoma 152
Montelukast reverses albuterol-induced b2-adrenoceptor tolerance in airway smooth muscle 150
Pathophysiology and pharmacological targets of VEGF in diabetic macular edema 150
Design, synthesis and pro-apoptotic antitumour properties of indole-based 3,5-disubstituted oxadiazoles 148
Pharmacokinetic-pharmacodynamic relationships of the anthracycline anticancer drugs 148
Therapeutic potential of sulindac hydroxamic acid against human pancreatic and colonic cancer cells 148
Inhibitory effect of suramin in rat models of angiogenesis in vitro and in vivo 148
Design, synthesis, and characterization of the antitumor activity of novel ceramide analogues 142
Phase I and pharmacologic study of weekly gemcitabine and paclitaxel in chemo-naïve patients with advanced non-small-cell lung cancer 141
In vitro investigation of sulindac derivatives as potential anticancer agents 140
Synthesis and evaluation of indole-containing 3,5-diarylisoxazoles as potential pro-apoptotic antitumour agents. 140
High-dose consolidation chemotherapy with Idarubicin and alkylating agents following induction with gemcitabine-epirubicin-paclitaxel in metastatic breast cancer: a dose finding study 140
Synthesis, characterization and evaluation of thiolated quaternary ammonium-chitosan conjugates for enhanced intestinal drug permeation 139
Conformationally restrained ceramide analogues: effects of lipophilic modifications on the antiproliferative activity 139
Pharmacogenetic foundations of therapeutic efficacy and adverse events of statins 139
Clinical utility of Next Generation Sequencing of plasma cell-free DNA for the molecular profiling of patients with NSCLC at diagnosis and disease progression 136
Sucrosomial® iron absorption studied by in vitro and ex-vivo models 135
Gemcitabine plus nab-paclitaxel induces PD-L1 mRNA expression in plasma-derived microvesicles in pancreatic cancer 135
EGFR-TKIs in non-small-cell lung cancer: Focus on clinical pharmacology and mechanisms of resistance 132
In vivo adenosine A(2B) receptor desensitization in guinea-pig airway smooth muscle: Implications for asthma 131
Manumycin inhibits ras signal transduction pathway and induces apoptosis in COLO320-DM human colon tumour cells 130
Evaluation of circulating microRNAs as diagnostic circulating biomarkers in cutaneous melanoma 129
Influence of polysaccharides on expression of membrane-associated muc1 in cultivated epithelial cells 128
The role of drug-drug interactions in prostate cancer treatment: Focus on abiraterone acetate/prednisone and enzalutamide 128
Endothelial nitric oxide synthase c.-813C>T predicts for proteinuria in metastatic breast cancer patients treated with bevacizumab-based chemotherapy 127
Farmacogenetica nelle neoplasie gastriche 126
Synthesis, characterization and evaluation of thiolated quaternary ammonium-chitosan conjugates for enhanced intestinal drug permeation 126
Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patients 124
Metabolism of 6-mercaptopurine in the erythrocytes, liver, and kidney of rats during multiple-dose regimens 123
Clinical pharmacology and drug-drug interactions of lenvatinib in thyroid cancer 123
New chitosan derivatives for the preparation of rokitamycin loaded microspheres designed for ocular or nasal administration 121
Blood-based PD-L1 analysis in tumor-derived extracellular vesicles: Applications for optimal use of anti-PD-1/PD-L1 axis inhibitors 121
Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study 119
Attività antiproliferativa dell’oleocantale in cellule umane di melanoma cutaneo maligno. 119
The role of nitric oxide in anthracycline toxicity and prospects for pharmacologic prevention of cardiac damage 117
Drug-drug interactions in breast cancer patients treated with CDK4/6 inhibitors 117
Erratum: Clinical pharmacology of monoclonal antibodies targeting PD-1 axis in urothelial cancers 117
null 110
Cross-Linked Hyaluronic Acid as Tear Film Substitute 109
ErbB in NSCLC as a molecular target: Current evidences and future directions 109
Nicotine Metabolite Ratio in Smokers: A Real World Experience 109
Pharmacological insights on novel oral selective estrogen receptor degraders in breast cancer 107
Reply to comments on: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients 105
Control of cell growth by ceramide analogues: a new strategy for anticancer drug development 104
Clinical pharmacology of monoclonal antibodies targeting anti-PD-1 axis in urothelial cancers 103
Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients 103
Totale 16.334
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.025
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.025
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021633 0 0 0 0 0 0 67 94 135 116 78 143
2021/20221.479 43 77 65 90 233 212 60 70 63 49 86 431
2022/20232.062 257 292 162 169 194 278 37 152 371 10 126 14
2023/20241.411 142 163 158 83 176 252 71 52 29 51 107 127
2024/20254.463 49 173 47 245 506 530 294 200 479 525 456 959
2025/20262.865 342 514 550 465 586 393 15 0 0 0 0 0
Totale 19.396